Lybrel Ads Shouldn’t Condemn Menstruation

Make a comment

lybrel1.jpgLast week, we noted that Wyeth’s new Lybrel birth control pill is arriving in pharmacies and, at the same time, noted that a provocative op-ed piece in The New York Times suggested the drug may become part of a trend to label menstruation as an unwanted disease. Karen Houppert, who wrote “The Curse: Confronting the Last Unmentionable Taboo, Menstruation,” argued that a war of sorts was quietly being declared on the menstrual cycle.

She suggested the marketing treats menstruation as an ailment in need of treatment and, therefore, a “barrage of advertising and research highlighting the debilitating effects of periods and the joys of menstrual suppression” can’t be far behind. In other words, Houppert wrote, the marketing may be good for Wyeth and other drugmakers, but not necessarily good for women.

So we ran a brief poll and what you thought - Is menstruation a disease that needs to be cured? The short-lived poll reflects a small turnout and the results aren’t scientific, but could be interpreted as a temperature reading. Marketeers, take note. Be careful how you characterize menstruation.

No - 36 votes, or 82 percent;
Yes - 8 votes, or 18 percent.

Jump to comments

Share

Comments are closed.

Subscribe

RSS Feed

Comments feed for this post only.

Tags

, ,

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/